Health
Insilico Medicine AI COVID tool uses Xeons – Fudzilla
Intel helps in COVID-19 research Industry veteran Alex Zhavoronkov who left the PC industry (ATI and AMD) to start the AI longevity focused Insilico Medicine, has announced AI-powered COVIDomic to power the COVID-19 basic and clinical research.
Insilico Medicine is a global leader in artificial intelligence for drug discovery and development, and the company is among the first in the world to embrace the AI technologies in tools in drug discoveries. Now the company realized that it could use AI on Intel Xeon architecture to launch a new system for COVID-19 basic and clinical research.
Insilico Medicine came up with COVIDomic, a foundational technology that enables scientists to use anonymized patient data to integrate with a variety o…
-
Noosa News20 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News19 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business21 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News21 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland